Affiliation:
1. Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CM Utrecht, The Netherlands
Abstract
Background: ACVIM developed and published guidelines for staging myxomatous mitral valve degeneration in dogs in 2009. An updated version was published in 2019. The present study aimed to investigate whether these guidelines are actually used by the intended public more than a decade after their first publication. Methods: An online survey was distributed among Dutch and Belgian veterinarians through online channels and mailing lists. Results: Of the 524 responses, only 363 complete surveys were analyzed. The ACVIM guidelines are used by 60% of the respondents. Veterinarians find it more difficult to differentiate stage B1 from B2 in asymptomatic dogs compared to diagnosing stage C. Three-quarters of the respondents would recommend echocardiography for an incidentally detected new murmur with an intensity of 3 out of 6 in an adult dog. Two-thirds of the respondents find coughing a convincing finding for stage C disease. Close to half of the respondents associate a horizontal, dull percussion line with pulmonary edema. For confirming cardiogenic pulmonary edema, 98% of the respondents used thoracic radiographs. Conclusions: Veterinary practitioners might not have the expected training and equipment to be able to apply the guidelines in their practices, especially in the differentiation of stage B1 from stage B2.
Reference40 articles.
1. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease;Atkins;J. Vet. Intern. Med.,2009
2. Management of incidentally detected heart murmurs in dogs and cats;Edwards;J. Am. Vet. Med. Assoc.,2015
3. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs;Keene;J. Vet. Intern. Med.,2019
4. van Vuuren, D., Vlaanderen, M., Pomp, M., and Geelen, J. (2023, October 21). SEO Arbeidsmarkt Dierenartsen. Available online: www.seo.nl.
5. Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: The EPIC study—A randomized clinical trial;Boswood;J. Vet. Intern. Med.,2016